{
    "NCT05508789": {
        "inclusion_criteria_match": [
            "0",
            "10"
        ],
        "exclusion_criteria_match": [
            "0"
        ],
        "relevance_explanation": "The patient's note mentions progressive memory loss and severe cognitive deficits, which are relevant to the study's focus on Alzheimer's Disease. The patient also indicates compliance with the trial protocol, which is relevant.",
        "relevance_score_R": 80,
        "eligibility_explanation": "The patient has significant neurological issues including jerking movements and severe cognitive deficits, which may indicate other neurological diseases affecting cognition. This potentially excludes the patient from the trial.",
        "eligibility_score_E": 40
    },
    "NCT06297590": {
        "inclusion_criteria_match": [
            "1",
            "2",
            "3",
            "4",
            "5",
            "6"
        ],
        "exclusion_criteria_match": [
            "0"
        ],
        "relevance_explanation": "The patient's note indicates progressive memory loss, cognitive deficits, and memory dysfunction, which are key symptoms of early symptomatic Alzheimer's Disease. The patient also shows compliance with the trial protocol, which is a positive aspect for participation.",
        "relevance_score_R": 85,
        "eligibility_explanation": "While the patient exhibits symptoms consistent with early symptomatic Alzheimer's Disease, the note does not provide specific information on the patient's BMI, MMSE score, CDR global score, or flortaucipir F18 PET criteria. Additionally, the patient has a history of serious or unstable illnesses, which is an exclusion criterion.",
        "eligibility_score_E": -85
    },
    "NCT05026866": {
        "inclusion_criteria_match": [
            "0",
            "2",
            "4"
        ],
        "exclusion_criteria_match": [
            "1",
            "0"
        ],
        "relevance_explanation": "The patient shows severe cognitive deficits and memory dysfunction, which indicates a possible advanced stage of Alzheimer's Disease, making them relevant to the study's target disease. However, the patient's severe cognitive deficits and dementia-like symptoms disqualify them from the trial.",
        "relevance_score_R": 40,
        "eligibility_explanation": "The patient's severe cognitive deficits and memory dysfunction, along with the presence of dementia-like symptoms, indicate they do not meet the inclusion criteria for preclinical Alzheimer's Disease. Therefore, their eligibility score is lower than the relevance score.",
        "eligibility_score_E": 20
    },
    "NCT06653153": {
        "inclusion_criteria_match": [
            "2",
            "3",
            "5"
        ],
        "exclusion_criteria_match": [
            "0",
            "1"
        ],
        "relevance_explanation": "The patient's note indicates severe cognitive deficits and memory dysfunction, which are relevant to the study of early Alzheimer's disease. The patient also has adequate literacy, vision, and hearing, and has a stable medication regimen, which are important for study participation.",
        "relevance_score_R": 70,
        "eligibility_explanation": "The patient has severe cognitive deficits, which likely excludes them from the study due to the requirement for minimal cognitive impairment. Additionally, the presence of severe neurological deficits and memory dysfunction also disqualifies the patient.",
        "eligibility_score_E": -70
    },
    "NCT06566170": {
        "inclusion_criteria_match": [
            "1",
            "2",
            "5"
        ],
        "exclusion_criteria_match": [
            "0"
        ],
        "relevance_explanation": "The patient's note indicates progressive memory loss and severe cognitive deficits, which are relevant to the study's focus on early symptomatic Alzheimer's Disease. The patient also shows compliance with the trial protocol, which is a positive aspect.",
        "relevance_score_R": 80,
        "eligibility_explanation": "The patient has severe cognitive deficits and memory dysfunction, which suggests advanced disease rather than early symptomatic stage. Additionally, the patient's history of severe cognitive deficits and jerking movements may indicate a stroke or other serious conditions that could interfere with study completion.",
        "eligibility_score_E": -80
    },
    "NCT06657768": {
        "inclusion_criteria_match": [
            "0",
            "1",
            "2",
            "3",
            "4",
            "5"
        ],
        "exclusion_criteria_match": [],
        "relevance_explanation": "The patient's symptoms and diagnostic findings are highly relevant to the study, which focuses on early symptomatic Alzheimer's Disease (AD). The patient's age, cognitive deficits, EEG findings, neuroimaging results, and biopsy findings all align with the target disease of the study.",
        "relevance_score_R": 95,
        "eligibility_explanation": "While the patient's profile aligns well with the inclusion criteria for early symptomatic Alzheimer's Disease, the study also requires healthy participants for Part A. The patient's progressive memory loss and other symptoms indicate a clinical condition rather than a healthy state. Therefore, the patient does not meet the eligibility criteria for either part of the study.",
        "eligibility_score_E": -95
    },
    "NCT06538116": {
        "inclusion_criteria_match": [
            "0",
            "1",
            "3",
            "4"
        ],
        "exclusion_criteria_match": [
            "0"
        ],
        "relevance_explanation": "The patient's note indicates a diagnosis consistent with Alzheimer's Disease, including progressive memory loss, cognitive deficits, and cerebral atrophy, which aligns with the inclusion criteria. The patient also has a reliable study partner and agrees to comply with the trial protocol.",
        "relevance_score_R": 85,
        "eligibility_explanation": "While the patient meets several inclusion criteria, they are of childbearing potential, which is an exclusion criterion. Therefore, they are ineligible for the trial.",
        "eligibility_score_E": -85
    },
    "NCT06220669": {
        "inclusion_criteria_match": [
            "5"
        ],
        "exclusion_criteria_match": [],
        "relevance_explanation": "The patient's note mentions relapsing-remitting multiple sclerosis (RRMS) and an EDSS score \u2264 5.5, which aligns with the inclusion criteria for the clinical trial.",
        "relevance_score_R": 80,
        "eligibility_explanation": "The patient meets the inclusion criteria for relapsing-remitting multiple sclerosis and has an EDSS score \u2264 5.5. However, there are no explicit exclusions noted in the patient's note.",
        "eligibility_score_E": 80
    },
    "NCT06809400": {
        "inclusion_criteria_match": [
            "9",
            "10",
            "11"
        ],
        "exclusion_criteria_match": [
            "0",
            "1",
            "3",
            "4",
            "5",
            "6",
            "7",
            "8",
            "9",
            "10"
        ],
        "relevance_explanation": "The patient's note indicates a diagnosis of Parkinson's disease and cognitive deficits, which are relevant to the study's target diseases. However, the patient also has significant neurological issues and other exclusions that outweigh the inclusions.",
        "relevance_score_R": 40,
        "eligibility_explanation": "While the patient has Parkinson's disease and meets some inclusion criteria, the presence of severe cognitive deficits, significant neurological disease, and other exclusions make it unlikely they would qualify for the trial.",
        "eligibility_score_E": -40
    },
    "NCT03997981": {
        "inclusion_criteria_match": [
            "14"
        ],
        "exclusion_criteria_match": [
            "0",
            "1",
            "4",
            "5"
        ],
        "relevance_explanation": "The patient note mentions the patient's age (62 years), ability to provide informed consent, and compliance with the trial protocol. However, the note also includes significant neurological conditions and history that are exclusionary.",
        "relevance_score_R": 40,
        "eligibility_explanation": "The patient's progressive memory loss, jerking movements, severe cognitive deficits, and cerebral atrophy indicate significant neurological conditions that are exclusionary. Additionally, there is no mention of the patient being on any neurotoxic chemotherapy, which is a requirement for the study.",
        "eligibility_score_E": -40
    }
}